J. Sanni

Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis

K. Kowdley, H. Wedemeyer, G. Hirschfield, 2022, JHEP reports : innovation in hepatology.

Evaluation of Radiographic Coxofemoral Measurements in Boerboel Dogs

R. Ajadi, J. Sanni, E. L. Sobayo, 2018, Folia Veterinaria.

Early assessment of safety and efficacy of tropifexor, a potent non bile-acid FXR agonist, in patients with primary biliary cholangitis: An interim analysis of an ongoing phase 2 study

H. Wedemeyer, G. Hirschfield, C. Schramm, 2018 .